UA37251C2 - Лекарственное средство для лечения или профилактики вирусной инфекции гепатита в и способ лечения вирусной инфекции гепатита в - Google Patents

Лекарственное средство для лечения или профилактики вирусной инфекции гепатита в и способ лечения вирусной инфекции гепатита в

Info

Publication number
UA37251C2
UA37251C2 UA93004171A UA93004171A UA37251C2 UA 37251 C2 UA37251 C2 UA 37251C2 UA 93004171 A UA93004171 A UA 93004171A UA 93004171 A UA93004171 A UA 93004171A UA 37251 C2 UA37251 C2 UA 37251C2
Authority
UA
Ukraine
Prior art keywords
viral hepatitis
prevention
substance
treatment
treating
Prior art date
Application number
UA93004171A
Other languages
English (en)
Ukrainian (uk)
Inventor
Філліп Аллен Фурман
Филлип Аллен Фурман
Джордж Роберт Пеінтер
Джордж Роберт Пейнтер
Original Assignee
Дзе Веллкам Фаундейшн Лімітед
Дзе Веллкам Фаундейшн Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Дзе Веллкам Фаундейшн Лімітед, Дзе Веллкам Фаундейшн Лимитед filed Critical Дзе Веллкам Фаундейшн Лімітед
Publication of UA37251C2 publication Critical patent/UA37251C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Настоящее изобретение относится к применению производных 1-(2-гидроксиметил-1,3-оксатиолан-5-ил)цитозина и их физиологически функциональных производных для лечения инфекций вируса гепатита В.
UA93004171A 1991-05-02 1992-05-01 Лекарственное средство для лечения или профилактики вирусной инфекции гепатита в и способ лечения вирусной инфекции гепатита в UA37251C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919109506A GB9109506D0 (en) 1991-05-02 1991-05-02 Therapeutic nucleosides
PCT/GB1992/000803 WO1992019246A1 (en) 1991-05-02 1992-05-01 Use of a 1,3-oxathiolan derivative for the treatment of hepatitis b infection

Publications (1)

Publication Number Publication Date
UA37251C2 true UA37251C2 (ru) 2001-05-15

Family

ID=10694346

Family Applications (1)

Application Number Title Priority Date Filing Date
UA93004171A UA37251C2 (ru) 1991-05-02 1992-05-01 Лекарственное средство для лечения или профилактики вирусной инфекции гепатита в и способ лечения вирусной инфекции гепатита в

Country Status (14)

Country Link
EP (1) EP0583274A1 (ru)
JP (1) JPH06506929A (ru)
AU (1) AU1662092A (ru)
CA (1) CA2102120A1 (ru)
GB (1) GB9109506D0 (ru)
IE (1) IE921363A1 (ru)
IL (1) IL101757A0 (ru)
MX (1) MX9203214A (ru)
MY (1) MY137298A (ru)
PT (1) PT100435B (ru)
RU (1) RU2104700C1 (ru)
UA (1) UA37251C2 (ru)
WO (1) WO1992019246A1 (ru)
ZA (1) ZA923185B (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5466806A (en) * 1989-02-08 1995-11-14 Biochem Pharma Inc. Processes for preparing substituted 1,3-oxathiolanes with antiviral properties
US6175008B1 (en) 1988-04-11 2001-01-16 Biochem Pharma Inc. Processes for preparing substituted 1,3-oxathiolanes with antiviral properties
IL100502A (en) * 1991-01-03 1995-12-08 Iaf Biochem Int PHARMACEUTICAL PREPARATIONS CONTAINING CIS-4-AMINO-1-) 2-HYDROXIMETHIL-1,3-OXETYOLEN-5-IL (-
GB9110874D0 (en) * 1991-05-20 1991-07-10 Iaf Biochem Int Medicaments
ZA923640B (en) * 1991-05-21 1993-02-24 Iaf Biochem Int Processes for the diastereoselective synthesis of nucleosides
MXPA01006425A (es) 1998-12-23 2002-06-04 Iaf Biochem Int Analogos de nucleosido antivirales.
AR049297A1 (es) * 2004-06-08 2006-07-12 Vertex Pharma Una composicion farmaceutica y dispersiones solidas de vx-950 (inhibidor de la proteasa de hcv ns3/4a) y proceso de obtencion
RU2331420C2 (ru) * 2005-12-08 2008-08-20 Роберт Шалвович Бибилашвили Противовирусное средство (варианты) и способ лечения на его основе

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5159067A (en) * 1987-01-28 1992-10-27 University Of Georgia Research Foundation Inc. 5'-Diphosphohexose nucleoside pharmaceutical compositions
US5047407A (en) * 1989-02-08 1991-09-10 Iaf Biochem International, Inc. 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
EP0472595A4 (en) * 1989-05-15 1992-07-08 Us Commerce Method of treatment of hepatitis
US5204466A (en) * 1990-02-01 1993-04-20 Emory University Method and compositions for the synthesis of bch-189 and related compounds

Also Published As

Publication number Publication date
IE921363A1 (en) 1992-11-04
JPH06506929A (ja) 1994-08-04
GB9109506D0 (en) 1991-06-26
IL101757A0 (en) 1992-12-30
PT100435A (pt) 1993-09-30
RU2104700C1 (ru) 1998-02-20
PT100435B (pt) 1999-08-31
MX9203214A (es) 1992-07-01
EP0583274A1 (en) 1994-02-23
MY137298A (en) 2009-01-30
ZA923185B (en) 1993-11-01
CA2102120A1 (en) 1992-11-03
AU1662092A (en) 1992-12-21
WO1992019246A1 (en) 1992-11-12

Similar Documents

Publication Publication Date Title
DE69232649D1 (de) Verwendung von 5-fluoro-2'-deoxy-3'-thiacytidin zur behandlung von hepatitis b
MD1224B2 (en) Application of nucleoside analogues with 1,3-oxathiolan for treatment of hepatitis B
UA66744C2 (en) 5,6-dichlorobenzimidazole derivatives, methods for the preparation thereof, pharmaceutical composition and method for treatment of viral infections
UA29429C2 (ru) Фармацевтическая композиция для лечения вирусных инфекций, способ получения композиции, способ лечения или профилактики вич-инфекции у человека
MY131388A (en) Inhibitors of hiv protease useful for the treatment of aids.
UA39158C2 (ru) Производные n4-оксикарбонил-5'-дезокси-5-фторцитидина и фармацевтический препарат на их основе
MY121548A (en) Compounds and methods for the treatment of cancer
NO922949L (no) Forbindelser og fremgangsmaater for inhibering av hiv- og beslektede virus
EP1001782A4 (en) 5,6-HETEROARYL-DIPYRIDO 2,3- $ i (b): 3 ', 2' - $ i (f)] AZEPINES AND THEIR USE IN THE PREVENTION OR TREATMENT OF HIV INFECTION
ES2125976T3 (es) Otros derivados de indol con accion antiviral.
DE69526937D1 (de) Verwendung von methanbisphosphonsäurederivaten zur behandlung von aufgelockerten prothesen
MY127808A (en) Use of dideoxy nucleoside analogues in the treatment of viral infections
ATE303154T1 (de) Verwendung von einem trifluridin derivat allein oder in kombination mit einem thymidin- phosphorylase-hemmer zur behandlung von hiv
EP0610444A4 (en) METHOD OF TREATING VIRAL DISEASES.
ES2160643T3 (es) Composiciones que contienen g-csf y proteina de union al tnf.
UA37251C2 (ru) Лекарственное средство для лечения или профилактики вирусной инфекции гепатита в и способ лечения вирусной инфекции гепатита в
AP9801286A0 (en) Therapeutic compounds.
MD960168A (ru) Способ и соединения для лечения вирусных инфекций
CA2100066A1 (en) Michellamines useful as antiviral agents, composition and method of treatment
MY124071A (en) Treatment of viral disease in swine
ATE204476T1 (de) Verwendung von 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazi e zur herstrllung eines medikaments zur behandlung von bestimmten schmerzen und ödem
EP0757697A4 (en) Use of agents which block intercellular adhesion molecule/receptor interaction in the treatment of respiratory viral infection
FI965114A7 (fi) Farmaseuttinen koostumus virusinfektioiden sekä valinnaisesti tulehdusten estoon ja (tai) hoitoon sekä niiden hoitomenetelmä
ES2014042A6 (es) Un procedimiento para la preparacion de una composicion de 1-(2'-desoxi -2' fluor -b- d- arabinofuranosil) -5-etiluracilo.
ATE255417T1 (de) Verwendung von bradykinin-antagonisten zur behandlung von viruserkrankungen